Recent experimental evidence has indicated that mitochondrial function is impaired in chondrocytes from patients with osteoarthritis (OA). In this Review, the authors discuss how this mitochondrial dysfunction might affect pathogenetic pathways in OA, such as cartilage degradation, and whether the mitochondria might provide useful prognostic or diagnostic biomarkers or act as potential targets for therapy in patients with OA.
- Francisco J. Blanco
- Ignacio Rego
- Cristina Ruiz-Romero